USA Measles Elimination at Risk Following Robert F. Kennedy Jr. Policies

The USA faces the potential loss of its measles elimination status in April after recording over 2,200 cases in 2025, the highest annual count since the early 1990s.Health experts attribute the resurgence to policy changes under Robert F. Kennedy Jr. as wealthy G20 figures call for tax increases on the super-rich to protect democracy from Trump.International concerns also focus on the Kurdish struggle in Syria against forces allegedly backed by Trump and Benjamin Netanyahu while Kim Kardashian signals an end to her feud with Taylor Swift.
Published:22 Jan
Tags
#Mexico#Türkiye#Spain#Syria#Italy#RobertFKennedyJr#Trump#KimKardashian#TaylorSwift#BenjaminNetanyahu#PaoloTrancassini#ChiaraAppendino#AnnaAscani#FabioMarcelli#AlJolani
Read more
LA Times The New Yorker Intelligencer Newsmax Fanpage.it Repubblica 20 Minutes
Discuss
Español
Français
Deutsch
Italiano
Svenska
36
Earth
USA
Europe
Tags
Feeds

#Politics

#

DonaldTrump

Trump Faces Rising Public Discontent and Immigration Agency Scrutiny

22 Jan
#

GleisiHoffmann

Gleisi Hoffmann Enters Brazil Senate Race While Italy Sets Justice Vote

22 Jan
#

JackSmith

Jack Smith Testifies as Trump Launches Peace Council During Davos Rally

22 Jan
#

DonaldTrump

Trump Threatens Greenland Annexation Sparking NATO Crisis and Market Crash

21 Jan
#

DonaldTrump

Trump Expands Executive Power With Global Interventions And Domestic Crackdowns

21 Jan
#

AhmadAlSharaa

Ahmad al-Sharaa and Mazloum Abdi Agree to Ceasefire in Northern Syria

21 Jan
#

AliKhamenei

Ali Khamenei Vows to Crush Protests as Death Toll in Iran Surpasses 5000

21 Jan
#

Trump

Trump Marks First Year of Second Term With Military and Economic Shifts

21 Jan /20 Jan
#

UrsulaVonDerLeyen

Ursula von der Leyen Vows Strong EU Response to Trump Over Greenland

20 Jan
#

DonaldTrump

Trump Threatens Greenland Annexation Following Capture of Maduro

20 Jan
1
#

DonaldTrump

Trump Discloses Emmanuel Macron Messages Proposing G7 with Russia

20 Jan
4
Stockholm, Sweden
+46 (0)8 525-171-42 Email